Cite
HARVARD Citation
Somaiah, N. et al. (2022). Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet oncology. 23 (9), pp. 1156-1166. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Somaiah, N. et al. (2022). Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet oncology. 23 (9), pp. 1156-1166. [Online].